{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:36:51Z","timestamp":1777275411708,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.09.176","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T23:44:43Z","timestamp":1539301483000},"page":"1703-1711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases"],"prefix":"10.1016","volume":"108","author":[{"given":"Tamires","family":"Cunha Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Henrique","family":"Gonzaga Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6592-3971","authenticated-orcid":false,"given":"Luiza Braga","family":"Ferreira dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleiton Moreira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Tupinamb\u00e1 Branquinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"de Lana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Ramos Gadelha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2344-5590","authenticated-orcid":false,"given":"\u00c2ngelo","family":"de F\u00e1tima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2018.09.176_bib0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2013.05.046","article-title":"Chagas disease: an overview of clinical and epidemiological aspects","volume":"62","author":"Nunes","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2018.09.176_bib0010","series-title":"Chagas Disease (American Trypanosomiasis)","author":"World Health Organization","year":"2016"},{"issue":"2","key":"10.1016\/j.biopha.2018.09.176_bib0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/CMR.00054-09","article-title":"Cardiac involvement with parasitic infections","volume":"23","author":"Hidron","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"22","key":"10.1016\/j.biopha.2018.09.176_bib0020","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1021\/jm3011004","article-title":"Phthalazine derivatives containing imidazole rings behave as Fe-SOD inhibitors and show remarkable anti-T. cruziactivity in immunodeficient-mouse mode of infection","volume":"55","author":"S\u00e1nchez-Moreno","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.176_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-698X-7-7","article-title":"Chagas disease: an impediment in achieving the millennium development goals in Latin America","volume":"7","author":"Franco-Paredes","year":"2007","journal-title":"BMC Int. Health Hum. Rights"},{"key":"10.1016\/j.biopha.2018.09.176_bib0030","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1021\/jm9004835","article-title":"Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania","volume":"52","author":"Cavalli","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.176_bib0035","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"N. Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.biopha.2018.09.176_bib0040","doi-asserted-by":"crossref","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","article-title":"Nifurtimox activation by trypanosomal type nitroreductases generates cytotoxic nitrile metabolites","volume":"286","author":"Hall","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.176_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.biopha.2018.09.176_bib0050","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1371\/journal.pntd.0001861","article-title":"J.W. Curran. is Chagas Disease really the \u201cnew HIV\/AIDS of the Americas?\u201d","volume":"6","author":"Tarleton","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2018.09.176_bib0055","first-page":"17","article-title":"Update on neglected tropical diseases of the Western Hemisphere","volume":"4","author":"Fischer","year":"2011","journal-title":"Infect. Dis. Res. Treat."},{"issue":"14","key":"10.1016\/j.biopha.2018.09.176_bib0060","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic chagas\u2019 cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.biopha.2018.09.176_bib0065","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 Disease","volume":"370","author":"Molina","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.176_bib0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J. Biomol. Screen."},{"issue":"6","key":"10.1016\/j.biopha.2018.09.176_bib0075","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1590\/0074-0276140156","article-title":"Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity","volume":"109","author":"Zingales","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.biopha.2018.09.176_bib0080","first-page":"1065","volume":"Vol. 2","author":"Miles","year":"2017"},{"key":"10.1016\/j.biopha.2018.09.176_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2010.05.004","article-title":"Schiff bases: a short review of their antimicrobial activities","volume":"2","author":"da Silva","year":"2011","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.biopha.2018.09.176_bib0090","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1747-0285.2011.01185.x","article-title":"Synthesis of aryl aldimines and their activity against fungi of clinical interest","volume":"78","author":"da Silva","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2018.09.176_bib0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jare.2018.03.007","article-title":"Schiff bases and their metal complex as urease inhibitors \u2013 a brief review","volume":"13","author":"de F\u00e1tima","year":"2018","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.biopha.2018.09.176_bib0100","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/molecules15020660","article-title":"Antimicrobial and antifungal activities of some new aryl azomethines","volume":"15","author":"Al-Kahraman","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2018.09.176_bib0105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/PL00008549","article-title":"Antimalarial activity of new gossypol derivatives","volume":"86","author":"Razakantoanina","year":"2000","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.176_bib0110","first-page":"87","article-title":"Copper(II) nitroaromatic Schiff base complexes: synthesis, biological activity and their interaction with DNA and albumins","volume":"28","author":"Martins","year":"2017","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.biopha.2018.09.176_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jphotobiol.2017.05.020","article-title":"Studies on free radical scavenging, cancer cell antiproliferation and calf thymus DNA interaction of Schiff bases","volume":"172","author":"da Silva","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.biopha.2018.09.176_bib0120","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1246\/bcsj.56.1107","article-title":"Synthetic control by internal interaction. The intramolecular Diels-Alder reactions of furan derivatives and \u03b1, \u03b2-unsaturated amides","volume":"56","author":"Toyonori","year":"1983","journal-title":"Bull. Chem. Soc. Jpn."},{"issue":"9364","key":"10.1016\/j.biopha.2018.09.176_bib0125","first-page":"-9376","article-title":"Reverse solvatochromism of imine dyes comprised of 5\u2010nitrofuran\u20102\u2010yl or 5\u2010nitrothiophen\u20102\u2010yl as electron acceptor and phenolate as electron donor","volume":"24","author":"de Melo","year":"2018","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.biopha.2018.09.176_bib0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1248\/yakushi1947.69.6-10_284","article-title":"Syntheses of furan derivatives. III","volume":"69","author":"Takahashi","year":"1949","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.biopha.2018.09.176_bib0135","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1021\/ja01130a048","article-title":"The reaction of certain substituted furfurals with aniline and aniline hydrochloride","volume":"74","author":"Drisko","year":"1951","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2018.09.176_bib0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/bscb.19490581002","article-title":"Azom\u00e9thines III d\u00e9riv\u00e9s du furfurald\u00e9hyde","volume":"58","author":"Rombaut","year":"1949","journal-title":"Bull. Soc. Chim. Belg."},{"key":"10.1016\/j.biopha.2018.09.176_bib0145","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/ja01516a001","article-title":"Intramolecular hydrogen bonding. II. The determination of Hammett sgma constants by intramolecular hydrogen bonding in Schiff\u2019s bases","volume":"81","author":"Baker","year":"1959","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2018.09.176_bib0150","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1248\/cpb.55.1070","article-title":"Synthesis, spectroscopic and cytotoxic studies of biologically active new Schiff bases derived from p-nitrobenzaldehyde","volume":"55","author":"Iqbal","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.biopha.2018.09.176_bib0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1550-7408.1967.tb02024.x","article-title":"Differentiation of Trypanosoma cruzi in culture","volume":"14","author":"Castellani","year":"1967","journal-title":"J. Protozool."},{"key":"10.1016\/j.biopha.2018.09.176_bib0160","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1208\/s12249-014-0156-1","article-title":"Preclinical formulations: insight, strategies, and practical considerations","volume":"15","author":"Shah","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2018.09.176_bib0165","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/AAC.01617-09","article-title":"Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas\u2019 disease treatment","volume":"54","author":"Batista","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2229-","key":"10.1016\/j.biopha.2018.09.176_bib0170","first-page":"2237","article-title":"In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas\u2019 disease","volume":"43","author":"Boiani","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.176_bib0175","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.ejmech.2009.04.015","article-title":"5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies","volume":"44","author":"Cabrera","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.176_bib0180","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/AAC.02353-14","article-title":"In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi","volume":"58","author":"Timm","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.176_bib0185","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0074-02761984000200008","article-title":"A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents","volume":"79","author":"Filardi","year":"1984","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.biopha.2018.09.176_bib0190","first-page":"389","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi","volume":"4","author":"Brener","year":"1962","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.biopha.2018.09.176_bib0195","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.biopha.2018.09.176_bib0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/CIA.S3787","article-title":"Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson\u2019s disease","volume":"4","author":"Truong","year":"2009","journal-title":"Clin. Interv. Aging"},{"issue":"5","key":"10.1016\/j.biopha.2018.09.176_bib0205","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/cc2351","article-title":"Clinical review: The management of hypertensive crises","volume":"7","author":"Varon","year":"2003","journal-title":"Crit. Care"},{"issue":"6","key":"10.1016\/j.biopha.2018.09.176_bib0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pt.2014.04.003","article-title":"Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects","volume":"30","author":"Patterson","year":"2014","journal-title":"Trends Parasitol."},{"issue":"24","key":"10.1016\/j.biopha.2018.09.176_bib0215","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1016\/j.bmc.2009.10.030","article-title":"New potent 5- nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies","volume":"17","author":"Rodr\u00edguez","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.176_bib0220","series-title":"Chapter 3 \u2013 Clinical Biochemistry and Hematology, The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents","first-page":"57","author":"Washington","year":"2012"},{"key":"10.1016\/j.biopha.2018.09.176_bib0225","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas\u2019 disease (American trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.biopha.2018.09.176_bib0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/AAC.47.1.223-230.2003","article-title":"Chemotherapy with benznidazole and itraconazole for mice infected with differentTrypanosoma cruzi clonal genotypes","volume":"47","author":"Toledo","year":"2003","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218350078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218350078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:39:42Z","timestamp":1777271982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218350078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":46,"alternative-id":["S0753332218350078"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.176","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}